Cornelis Punt

Prof. MD PhD

Full Professor, CCA - Cancer Treatment and quality of life

Specialization

medical oncology

Focus of research

Gastrointestinal cancer, with focus on colorectal cancer. Clinical and translational research. New drugs, pharmacogenomics, prognostic and predictive (bio)markers.

Key publications
Latest publications

Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group
van der Kruijssen, D. E. W., Elias, S. G., van de Ven, P. M., van Rooijen, K. L., Lam-Boer, J. ., Mol, L., Punt, C. J. A., Sommeijer, D. W., Tanis, P. J., Nielsen, J. D., Yilmaz, M. K., van Riel, J. M. G. H., Wasowiz-Kemps, D. K., Loosveld, O. J. L., van der Schelling, G. P., de Groot, J. W. B., van Westreenen, H. L., Jakobsen, H. L., Fromm, A. L., Hamberg, P., & 73 othersVerseveld, M., Jaensch, C., Liposits, G. I., van Duijvendijk, P., Oulad Hadj, J., van der Hoeven, J. A. B., Trajkovic, M., de Wilt, J. H. W., Koopman, M., Vincent, J., Wegdam, J. A., Haberkorn, B. C. M., van der Harst, E., Hendriks, M. P., Schreurs, W. H. H., Cense, H. A., Rietbroek, R. C., de Gier, M-J., van Breugel, E. A., de Vos, A. I., Brosens, R. P. M., Doornebosch, P. G., de Jongh, F. E., Vles, W. J., den Boer, M. O., Leijtens, J. W. A., Gelderblom, A. J. H., Peeters, K. C. M. J., Kuenen, B. C., Pultrum, B. B., van Dodewaard-de Jong, J. M., Consten, E. C. J., van de Wouw, A. J. Y., Konsten, J. L. M., Hoekstra, R., Lutke Holzik, M. F., Vos, A. H., van Hoogstraten, M. J., Schlesinger, N. H., Creemers, G-J., de Hingh, I. H. J. T., Kjær, M. L., Petersen, L. N., Seiersen, M., Altaf, R., van Cruijsen, H., Hess, D. A., van Leeuwen-Snoeks, L. L., Pronk, A., Baeten, C. I. M., van der Deure, W. M., Bosscha, K., Schut, H., Leclercq, W. K. G., Simkens, L. H. J., Reijnders, K., van Arkel, K., van Grevenstein, W. M. U. H., van de Ven, A. W. H., Vuylsteke, R. J. C. L. M., Kuijer, P., Bakker, S. D., Goei, H., Helgason, H. H., van Acker, G. J. D., Temizkan, M., van Tilburg, M. W. A., Gerhards, M. F., Kerver, E. D., Gootjes, E., Nieboer, P., Bleeker, W. A. & Bleeker, G. R., Sept 2024, In: Annals of Oncology. 35, 9, p. 769-779 11 p.
Research output: Contribution to journal › Article › Academic › peer-review
Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation
Michiel Zeeuw, J., Wesdorp, N. J., Ali, M., Bakker, A-J. J. J., Voigt, K. R., Starmans, M. P. A., Roor, J., Kemna, R., van Waesberghe, J. H. T. M., van den Bergh, J. E., Nota, I. M. G. C., Moos, S. I., van Dieren, S., van Amerongen, M. J., Bond, M. J. G., Chapelle, T., van Dam, R. M., Engelbrecht, M. R. W., Gerhards, M. F., van Gulik, T. M., & 20 othersHermans, J. J., de Jong, K. P., Klaase, J. M., Kok, N. F. M., Leclercq, W. K. G., Liem, M. S. L., van Lienden, K. P., Quintus Molenaar, I., Patijn, G. A., Rijken, A. M., Ruers, T. M., de Wilt, J. H. W., Verpalen, I. M., Stoker, J., Grunhagen, D. J., Swijnenburg, R-J., Punt, C. J. A., Huiskens, J., Verhoef, C. & Kazemier, G., Aug 2024, In: European journal of cancer (Oxford, England. 207, p. 114185 114185.
Research output: Contribution to journal › Article › Academic › peer-review
Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
Bond, M. J. G., van Smeden, M., Degeling, K., Cremolini, C., Schmoll, H-J., Antoniotti, C., Lonardi, S., Murgioni, S., Rossini, D., Ibach, S., Koopman, M., Swijnenburg, R-J., Punt, C. J. A., May, A. M. & Kwakman, J. J. M., 1 Jul 2024, In: JCO clinical cancer informatics. 8, e2400037.
Research output: Contribution to journal › Article › Academic › peer-review
All publications

Cornelis Punt

Specialization

Focus of research

Cancer immunotherapy--revisited

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

From tumour heterogeneity to advances in precision treatment of colorectal cancer

Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group

Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation

Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Cornelis Punt

Specialization

Focus of research

Cancer immunotherapy--revisited

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

From tumour heterogeneity to advances in precision treatment of colorectal cancer

Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group

Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation

Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Amsterdam UMC makes use of cookies